Cagrilintide + Semaglutide

Cagrilintide + Semaglutide

Sale!

Cagrilintide + Semaglutide is a specialized peptide formulation that combines Semaglutide and Cagrilintide to support metabolic research and wellness applications. This dual-peptide blend is designed to study appetite regulation, insulin sensitivity, and weight management by targeting pathways involved in glucose regulation and energy metabolism.

$105.00

Buy more, save more!

  • Save 2%

    Buy 3, get $2.50 off each

    $105.00
    Per item: $102.50
    Total price: $307.50
  • Save 4%

    Buy 5, get $3.75 off each

    $105.00
    Per item: $101.25
    Total price: $506.25
  • Save 7%

    Buy 10, get $7.50 off each

    $105.00
    Per item: $97.50
    Total price: $975.00
$120.00$105.00
Selected Features
Strength Variation
resetClear
Add to Wishlist
Compare
SKU: N/A
Category:
icon

99+% PURITY

All peptides are third-party lab tested.

icon

SECURE PAYMENT

Your payments are secure with our private security network.

icon

FREE SHIPPING

for orders over $250

Description
Additional information
Reviews (0)

Cagrilintide + Semaglutide is a dual-peptide combination featuring an amylin analogue and a GLP-1 receptor agonist. This combination is investigated for its synergistic effects on appetite regulation, glucose balance, and energy metabolism through the simultaneous activation of amylin and GLP-1 receptor pathways.

Cagrilintide, an amylin analogue, is being explored alongside semaglutide for its role in sustained weight management research. Amylin-related pathways are associated with satiety signalling in both homeostatic and reward-related brain regions. Semaglutide influences appetite regulation, insulin production, glucagon activity, and gastric emptying through GLP-1 receptor activation. 

Ongoing clinical and laboratory studies continue to evaluate the potential of this combination for long-term metabolic and weight management applications.

Strength Variation

, ,

Reviews

There are no reviews yet.

Be the first to review “Cagrilintide + Semaglutide”

Your email address will not be published. Required fields are marked *